You just read:

CIPHER PHARMACEUTICALS COMPLETES PATIENT ENROLMENT IN CIP-ISOTRETINOIN PHASE III SAFETY STUDY

News provided by

Cipher Pharmaceuticals Inc.

Oct 29, 2010, 08:30 ET